Copyright
©The Author(s) 2020.
World J Clin Cases. Jan 26, 2020; 8(2): 425-435
Published online Jan 26, 2020. doi: 10.12998/wjcc.v8.i2.425
Published online Jan 26, 2020. doi: 10.12998/wjcc.v8.i2.425
Figure 3 Excellent hematological response following mannitol-gentamycin or polyethylene-rifaximin treatments in the refractory severe aplastic anemia patient.
Mannitol-gentamycin treatments were performed on days 1, 31, and 92. Polyethylene-rifaximin (PR) treatments were performed on days 158, 189, 217, 248, 278, and 337. A transiently high responsiveness to recombinant human granulocyte colony stimulating factor was noted around day 17, and since then white blood cell counts (/µL) were maintained at relatively low levels. Plt (×10 /µL) and Ret (×10 /µL) levels increased rapidly, with each precipitous decrease occurring 7-8 wk after mannitol-gentamycin or PR treatments. Monthly administration of PR treatments was able to result in a stable hematopoietic response. Hb (g/dL) levels increased steadily.
- Citation: Zhao XC, Zhao L, Sun XY, Xu ZS, Ju B, Meng FJ, Zhao HG. Excellent response of severe aplastic anemia to treatment of gut inflammation: A case report and review of the literature. World J Clin Cases 2020; 8(2): 425-435
- URL: https://www.wjgnet.com/2307-8960/full/v8/i2/425.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i2.425